๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vasoreactivity Testing with Inhaled Iloprost and Nitric Oxide in Pulmonary Arterial Hypertension

โœ Scribed by J. Phan; P. Macdonald; A. Keogh; E. Kotlyar; R. Pritchard; C. Hayward

Book ID
116527792
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
83 KB
Volume
20
Category
Article
ISSN
1443-9506

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Inhaled nitric oxide reduces pulmonary a
Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension
โœ Findlay, James Y. ;Harrison, Barry A. ;Plevak, David J. ;Krowka, Michael J. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 85 KB

## Pulmonary artery hypertension in association with liver failure (portopulmonary hypertension [PPHTN] ) is a significant barrier to liver transplantation because patients with this condition have a very high mortality when transplantation is undertaken. Inhaled nitric oxide (NO), a potent pulmon